An Impact of Liver Cirrhosis On Haematological, Renal & Hepatic Parameters
An Impact of Liver Cirrhosis On Haematological, Renal & Hepatic Parameters
Introduction
Liver disease is a significant global health issue also has profound implications for other organ
leading to liver failure, cirrhosis, and cancer. [1] systems, including the haematological and renal
Alcohol is a major cause, accounting for 5% of systems. In this article, we will explore the
deaths in India. [2] Preventing and early detection haematological, renal, and liver function
are crucial. [3] Diagnosis involves a clinical parameters commonly observed in patients with
features like ascites, bleeding, or hepatic cirrhosis of the liver. [5]
encephalopathy. [4] Liver biopsy to confirm
Objective of the Study: To Assess & Compare the
cirrhosis, requiring a multidisciplinary approaches.
haematological, renal, and liver function
[5] Understanding liver disease molecular
parameters among cases and controls.
mechanisms is vital for developing new treatments
and reducing cirrhosis-related mortality. Material and Methods
Cirrhosis of the liver is a chronic liver disease The study was conducted at Index Medical College
characterized by the replacement of healthy liver hospitals in Indore. This study included individuals
tissue with scar tissue, leading to impaired liver with chronic alcoholic liver disease who sought
function. It is a progressive condition that can medical attention at Gastroenterology departments
result from various etiologies such as chronic of Medical College hospitals located in Indore. A
alcohol abuse, viral hepatitis, non-alcoholic fatty total of 200 people is involved in this study (100
liver disease (NAFLD), and autoimmune liver Experimental & 100 Control) with an inclusion
diseases. Cirrhosis not only affects the liver but
criteria. The statistical analysis was carried out • Collects 4mL blood sample from participants,
using SPSS software. and
• Transfer 2mL to EDTA tube and another 2mL
Biochemical Investigations
to Serum Tube.
• Haematological Investigation: Haemoglobin
Sampling Criteria:
(Cyanmethemoglobin method) & platelet
counts (Optical platelet counting). Inclusion Criteria for Cases: Liver Cirrhosis
• Kidney Function Test: Urea (DAM method), subjects, Age- 30-60 years in both males and
creatinine (Jaffe’s method). females.
• Liver Function Test: Total Bilirubin, Direct
Exclusion Criteria for Cases: Contagious
Bilirubin (Diazo Method), Serum SGOT,
diseases, Rheumatoid arthritis, multiple myeloma,
SGPT, ALP (IFCC method, kinetic), Total
hepatitis B & C, hepatocellular carcinoma.
Protein (Biuret Method), Albumin (Bromocre-
sol green Method). Inclusion Criteria for Control: Subjects free from
cirrhosis of liver, liver disease & non-alcoholic at
Samples Collection:
age 30-60 years in both gender.
• After obtaining informed consent form from
Results
patients.
• Blood Samples are collected from General
Medicine Ward.
Table 1: Age distribution among cases and controls
Age Cases No. Controls No.
30-40 34 30
41 – 50 20 26
51 – 60 46 44
Total 100 100
Table 2: Clinical features of CLD Cases
Clinical features Cases
No. %
Yellowish of the skin and the eyes 54 54
Itchy skin 24 24
Ascites 07 07
Blood in vomiting 06 06
Swollen abdomen & legs 09 09
Total 100 100
Table 3: Haematological parameters among case and controls
Variables Groups Mean & SD P Value
Haemoglobin (g/dl) Case 9.4± 2.1 <0.0001
Control 13.0±2.6
Platelet Count (lakh cells/cu.mm) Case 1.26±0.43 <0.0001
Control 2.71±1.08
Table 4: Renal function parameters among case and controls.
Variables Groups Mean & SD P Value
Urea (mg/dl) Case 13.06±1.02 0.0001
Control 25.13±6.04
Creatinine (mg/dl) Case 1.14±0.26 <0.0001
Control 0.8±0.3
Table 5: Liver function parameters among case and controls.
Variables Groups Mean & SD P Value
Total Bilirubin (mg/dl) Case 5.5±2.1 <0.0001
Control 0.88±0.61
Direct Bilirubin (mg/dl) Case 2.4±1.2 0.0001
Control 0.4±0.2
AST (IU/L) Case 76.1±22.7 <0.0001
Control 20.9±7.2
ALT (IU/L) Case 58± 18.4 <0.0001
Control 23.1±9.2
AST/ALT ratio Case 1.42±0.44 <0.0001
Control 1.0±0.29
ALP (IU/L) Case 148.6 ± 31.2 0.0001
Control 88.6±18.7
Total Protein (g/dl) Case 6.6 ± 2.04 0.259
Control 6.99± 1
Albumin (g/dl) Case 3.1 ± 0.98 <0.0001
Control 4.7±1.4
A : Gratio Case 0.93±0.26 <0.0001
Control 1.6 ± 0.41
The study findings demonstrated Haemoglobin sequestration and decreased TPO (Thrombopoietin)
concentration and platelet count are highly production. Abnormal hematologic indices lead to
statistically significant in a Liver Cirrhosis Cases, poor prognosis and increased mortality.
Urea are statistically significant while Creatinine is
References
a highly statistically significant in a Liver Cirrhosis
Cases, and Total Bilirubin, AST, ALT and 1. Briones-Orta MA, Avendano-Vazquez SE,
Albumin are highly statistically significant, while Aparicio-Bautista DI, Coombes JD, Weber
Direct Bilirubin & ALP are statistically significant. GF, Syn WK. Osteopontin splice variants and
polymorphisms in cancer progression and
Total Protein is statistically not significant in a
prognosis. Biochimica et Biophysica Acta
Liver Cirrhosis Cases.
(BBA) - Reviews on Cancer. 2017 Aug;
Discussion 1868(1):93–108.
2. Boguslawska J, Sokol E, Rybicka B, Czubaty
In our studied data the Hemoglobin level, Platelets
A, Rodzik K, Piekielko-Witkowska A. mi-
count, Kidney Function test and Liver Function test
croRNAs target SRSF7 splicing factor to mod-
parameters are impaired as compared with control
ulate the expression of osteopontin splice vari-
groups. Acc. to Longo et al. The Prominent
ants in renal cancer cells. Gene. 2016 Dec;
Elevated level of AST through the MI Injury &
595(2):142–9.
mild elevated in the cirrhosis of liver, ALT is
3. Cui G, Chen J, Wu Z, Huang H, Wang L,
elevated in the chronic liver disease & chronic
Liang Y, et al. Thrombin cleavage of osteo-
alcoholism, ALP is elevated in the inflammation of
pontin controls activation of hepatic stellate
the bone disorder, Total & direct Bilirubin level is
cells and is essential for liver fibrogenesis.
increased due to Obstruction of hepatic biliary
Journal of Cellular Physiology [Internet]. 2018
disorders. [6] As C.A. Burtis also mentioned,
[cited 2024 Mar 21]; 234(6):8988–97.
Increase in aminotransferases (AST and ALT) is
4. Hu J, Li G, Zhang P, Zhuang X, Hu G. A
due to increased permeability of injured hepatic
CD44v+ subpopulation of breast cancer stem-
cell and release of the cytosolic inflammatory
like cells with enhanced lung metastasis capac-
contents. [7] Acc. to Murali AR, et al, cases shows
ity. Cell Death & Disease. 2017 Mar;
lower serum levels of heamoglobin, platelet count,
8(3):e2679–9.
total protein, and albumin as compared to controls,
5. Clemente N, Raineri D, Cappellano G, Boggio
indicating chronic disease and liver hepatic cell
E, Favero F, Soluri MF, et al. Osteopontin
decline in synthesis function. [8] As decreased
Bridging Innate and Adaptive Immunity in Au-
platelet count in cases indicates hypersplenism-
toimmune Diseases. Journal of Immunology
resistance of the hepatic due to portal hypertension.
Research. 2016; 2016:1–15.
[8] Low platelet count is also a marker of alcoholic
6. Longo, Dan L, et al. Harrison’s Gastroenterol-
cirrhosis. [8] Acc. to Gonzalez-Casas R, et al,
ogy and Hepatology. New York, Mcgraw-Hill
Anemia is caused by repeated varices bleeding,
Medical, 2013.
alcoholism, folic acid and vitamin B12 deficiency
7. Tietz Textbook of Clinical Chemistry and Mo-
due to inadequate intake of diet. [9]
lecular Diagnostics, 4th ed., C.A. Burtis, E.R.
Conclusion Ashwood, D.E. Bruns (Eds.). Elsevier Inc.
(2006).
Liver Cirrhosis shows Hematologic Abnormalities 8. Murali AR, Attar BM, Katz A, Kotwal V,
and Public Health Issues. Patients shows impaired
Clarke P. Utility of Platelet Count for Predict-
kidney function tests. Study evaluates mechanisms
ing Cirrhosis in Alcoholic Liver Disease:
regulating hemostasis, coagulation, and
Model for Identifying Cirrhosis in a US Popu-
fibrinolysis. Anemia in cirrhosis linked to lation. 2015Feb21; 30(8).
hemorrhage, iron deficiency, and nutrition. Major
thrombocytopenia mechanisms include platelet